News tagged ‘ImmuneSystem’ clear
- Dana-Farber scientists report in the Journal of Clinical Investigation they have developed a tumor vaccine based on the patient’s tumor to create a strong and selective immune response in some chronic lymphocytic leukemia patients.
Tags: ImmuneSystem, Leukemia
- Dana-Farber scientists have demonstrated a new strategy for treating autoimmune disease that successfully blocked the development of rheumatoid arthritis in a mouse model. They say it holds promise for improved treatment of arthritis and other autoimmune disorders in people.
- A clinical trial for advanced melanoma caused growths to recede or stabilize in half of the participants by blocking a protein interaction that prevents T cells from attacking cancerous cells, reports lead author Stephen Hodi, MD.
Tags: ImmuneSystem, Melanoma
- In a study that seems to pivot on a paradox, scientists at Dana-Farber Cancer Institute have used an immune system stimulant as an immune system suppressor to treat a common, often debilitating side effect of donor stem cell transplantation in cancer patients.
Tags: BasicResearch, GraftVersusHost, ImmuneSystem
- A section of the AIDS virus's protein envelope known as the V3 loop and
once considered an improbable target for a vaccine now appears to be one
of the most promising, according to research authored by Dana-Farber's
Ruth Ruprecht, MD, PhD.
Tags: BasicResearch, ImmuneSystem
- Dana-Farber researchers have found that the basic cause of age-related
health decline is malfunctioning telomeres — the end-caps on cells'
chromosomes that protect them against DNA damage.
Tags: ImmuneSystem, Genetics
- Dana-Farber researchers received the grant from the Defense Advanced
Research Projects Agency and the Army Research Office to develop a
treatment against known, unknown, naturally occurring, or engineered
Tags: Grants, ImmuneSystem
- Dana-Farber Cancer Institute scientists identify cells in mice that
prevent the immune system from attacking the animals' own cells,
protecting them from autoimmune diseases.
- The use of monoclonal antibodies to activate an immune-system response
to abnormal cells resulted in a significant increase in survival time in
patients with metastatic melanoma, report Dana-Farber researchers.
Tags: ImmuneSystem, Melanoma, TranslationalResearch